These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 16282221)
1. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes. Gary-Bobo M; Elachouri G; Scatton B; Le Fur G; Oury-Donat F; Bensaid M Mol Pharmacol; 2006 Feb; 69(2):471-8. PubMed ID: 16282221 [TBL] [Abstract][Full Text] [Related]
2. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Bensaid M; Gary-Bobo M; Esclangon A; Maffrand JP; Le Fur G; Oury-Donat F; Soubrié P Mol Pharmacol; 2003 Apr; 63(4):908-14. PubMed ID: 12644592 [TBL] [Abstract][Full Text] [Related]
3. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. Jbilo O; Ravinet-Trillou C; Arnone M; Buisson I; Bribes E; Péleraux A; Pénarier G; Soubrié P; Le Fur G; Galiègue S; Casellas P FASEB J; 2005 Sep; 19(11):1567-9. PubMed ID: 16009704 [TBL] [Abstract][Full Text] [Related]
4. Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity. Tam J; Godlewski G; Earley BJ; Zhou L; Jourdan T; Szanda G; Cinar R; Kunos G Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E457-68. PubMed ID: 24381003 [TBL] [Abstract][Full Text] [Related]
5. The CB-1 receptor antagonist rimonabant modulates the interaction between adipocytes and pancreatic beta-cells in vitro. Ülgen F; Kühn MC; Cupisti K; Herder C; Willenberg HS; Schott M; Scherbaum WA; Schinner S Exp Clin Endocrinol Diabetes; 2011 Jan; 119(1):41-6. PubMed ID: 20658443 [TBL] [Abstract][Full Text] [Related]
6. The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake. Thornton-Jones ZD; Kennett GA; Benwell KR; Revell DF; Misra A; Sellwood DM; Vickers SP; Clifton PG Pharmacol Biochem Behav; 2006 Jun; 84(2):353-9. PubMed ID: 16814374 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoid type 1 receptor: another arrow in the adipocytes' bow. Bellocchio L; Cervino C; Vicennati V; Pasquali R; Pagotto U J Neuroendocrinol; 2008 May; 20 Suppl 1():130-8. PubMed ID: 18426512 [TBL] [Abstract][Full Text] [Related]
8. SDF7, a group of Scoparia dulcis Linn. derived flavonoid compounds, stimulates glucose uptake and regulates adipocytokines in 3T3-F442a adipocytes. Beh JE; Khoo LT; Latip J; Abdullah MP; Alitheen NB; Adam Z; Ismail A; Hamid M J Ethnopharmacol; 2013 Oct; 150(1):339-52. PubMed ID: 24029250 [TBL] [Abstract][Full Text] [Related]
9. Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes. Perwitz N; Wenzel J; Wagner I; Büning J; Drenckhan M; Zarse K; Ristow M; Lilienthal W; Lehnert H; Klein J Diabetes Obes Metab; 2010 Feb; 12(2):158-66. PubMed ID: 19895638 [TBL] [Abstract][Full Text] [Related]
14. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism. Sarnataro D; Pisanti S; Santoro A; Gazzerro P; Malfitano AM; Laezza C; Bifulco M Mol Pharmacol; 2006 Oct; 70(4):1298-306. PubMed ID: 16822929 [TBL] [Abstract][Full Text] [Related]
15. The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats. Serrano A; Del Arco I; Javier Pavón F; Macías M; Perez-Valero V; Rodríguez de Fonseca F Neuropharmacology; 2008 Jan; 54(1):226-34. PubMed ID: 17467748 [TBL] [Abstract][Full Text] [Related]
16. CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice. Jourdan T; Djaouti L; Demizieux L; Gresti J; Vergès B; Degrace P Diabetes; 2010 Apr; 59(4):926-34. PubMed ID: 20110567 [TBL] [Abstract][Full Text] [Related]
17. The Effect of Growth Hormone on Lipid Accumulation or Maturation in Adipocytes. Zhang Y; Yu H; Gao P; Chen J; Yu C; Zong C; Lu S; Li X; Ma X; Liu Y; Wang X Cell Physiol Biochem; 2016; 39(6):2135-2148. PubMed ID: 27802441 [TBL] [Abstract][Full Text] [Related]
18. Noladin ether acts on trabecular meshwork cannabinoid (CB1) receptors to enhance aqueous humor outflow facility. Njie YF; Kumar A; Qiao Z; Zhong L; Song ZH Invest Ophthalmol Vis Sci; 2006 May; 47(5):1999-2005. PubMed ID: 16639008 [TBL] [Abstract][Full Text] [Related]
19. Motilin stimulates preadipocyte proliferation and differentiation and adipocyte lipid storage. Miegueu P; Cianflone K; Richard D; St-Pierre DH Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E758-66. PubMed ID: 21771971 [TBL] [Abstract][Full Text] [Related]
20. The endocannabinoid system: a new target for the regulation of energy balance and metabolism. Després JP Crit Pathw Cardiol; 2007 Jun; 6(2):46-50. PubMed ID: 17667864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]